amyloid beta peptide vaccine (Daiichi Sankyo)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameamyloid beta peptide vaccine (Daiichi Sankyo)
Drug Alias NameRGD-DiTox[382-401]-KK-ABetaRGD-DiTox[382-401]-KK-ABeta[1-13]
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionBeta amyloid A4 protein inhibitorsBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A